首页 › 基金 › Matrix Capital Management Company, LP › AURA
Matrix Capital Management Company, LP 对 AURA 的持仓历史
AURA BIOSCIENCES INC · 医疗保健
Matrix Capital Management Company, LP 在 Q1 2026 的 13F 申报中披露持有 AURA(AURA BIOSCIENCES INC)6,922,870 股,市值约 US$46.3M,约占其申报组合的 100.00%,在其申报持仓中市值排名第 1 位。 Matrix Capital Management Company, LP 最近 11 个申报季度中有 11 个季度披露了 AURA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
Matrix Capital Management Company, LP 对 AURA 的持仓演变
Matrix Capital Management Company, LP 于 Q3 2023 首次披露 AURA 持仓:5,362,870 股(约 US$48.1M)。 该持仓在 Q3 2024 达到峰值 6,922,870 股,市值约 US$61.7M。 在 11 次申报中,Matrix Capital Management Company, LP 1 次增持、0 次减持、9 次保持不变。 最近一期申报(Q1 2026)显示持股 6,922,870 股、市值约 US$46.3M。 持仓曾出现大幅变动:Q4 2023 增持约 29% (随后一个季度股价下跌 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 5.36M | $48.10M | 新进 |
| Q4 2023 | 6.92M | $61.34M | 增持 |
| Q1 2024 | 6.92M | $54.34M | 持有 |
| Q2 2024 | 6.92M | $52.34M | 持有 |
| Q3 2024 | 6.92M | $61.68M | 持有 |
| Q4 2024 | 6.92M | $56.91M | 持有 |
| Q1 2025 | 6.92M | $40.57M | 持有 |
| Q2 2025 | 6.92M | $43.34M | 持有 |
| Q3 2025 | 6.92M | $42.78M | 持有 |
| Q4 2025 | 6.92M | $37.73M | 持有 |
| Q1 2026 | 6.92M | $46.31M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AURA 与 13F 数据
AURA(AURA BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 AURA,申报仓位最大的包括:TCG Crossover Management, LLC (US$67.7M), MONTANOVA CAPITAL, LLC (US$51.2M), Frazier Life Sciences Management, L.P. (US$50.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AURA 的基金
- TCG Crossover Management, LLC 9.53M 股 · $67.69M · Q2 2026
- MONTANOVA CAPITAL, LLC 7.21M 股 · $51.16M · Q2 2026
- Frazier Life Sciences Management, L.P. 7.10M 股 · $50.41M · Q2 2026
- Long Focus Capital Management, LLC 5.12M 股 · $36.35M · Q2 2026
- Caligan Partners LP 4.30M 股 · $30.52M · Q2 2026
- FCPM III SERVICES B.V. 4.05M 股 · $28.78M · Q2 2026
- Medicxi Ventures Management (Jersey) Ltd 3.04M 股 · $21.58M · Q2 2026
- Nantahala Capital Management, LLC 2.95M 股 · $20.95M · Q2 2026
- EcoR1 Capital, LLC 1.67M 股 · $11.83M · Q2 2026
- Redmile Group, LLC 1.67M 股 · $11.83M · Q2 2026
- Trails Edge Capital Partners, LP 1.44M 股 · $10.25M · Q2 2026
- Foresite Capital Management VI LLC 1.33M 股 · $9.47M · Q2 2026
更多关于 Matrix Capital Management Company, LP
常见问题
How long has Matrix Capital Management Company, LP held AURA?
Matrix Capital Management Company, LP has disclosed AURA holdings in 11 of the last 11 reported quarters, going back to Q3 2023.
What is Matrix Capital Management Company, LP's current position in AURA?
As of Q1 2026, Matrix Capital Management Company, LP holds 6.92M shares of AURA (AURA BIOSCIENCES INC), valued at $46.31M, representing 100.00% of its reported portfolio and ranking #1.
Has Matrix Capital Management Company, LP been buying or selling AURA?
In the latest 13F filing (Q1 2026), Matrix Capital Management Company, LP held unchanged its position in AURA. The position peaked in Q3 2024 at 6.92M shares.
Which other funds hold AURA?
Other major institutional holders of AURA include TCG Crossover Management, LLC, MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.